EP4143183
HETEROCYCLIC GLP-1 AGONISTS
:
EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á Íslandi:
28.4.2021:
22.10.2025:
21795712.5
:
27.4.2041:
27.4.2026
:
HETEROCYCLIC GLP-1 AGONISTS
28.4.2021
22.10.2025
27.4.2026
:
Gasherbrum Bio, Inc.:
611 Gateway Blvd. Suite 223, South San Francisco, California 94080, US
:
JENNINGS, Andrew:
San Francisco, California 94121, US
:
LEI, Hui:
Shanghai 201210, CN
:
LIN, Xichen:
Shanghai 201210, CN
:
MENG, Qinghua:
Shanghai 201210, CN
:
PCT/CN2020/087776:
29.4.2020:
WO
:
PCT/CN2020/105865:
30.7.2020:
WO
:
CN2021090645:
28.4.2021
:
C07D 405/14, C07D 405/12, C07D 413/14, C07D 471/04, A61P 3/10, A61K 31/496, A61K 31/4545, A61K 31/538